Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Molecular Biology Reports
|
March 4, 2011
Using the recognition code to swap homeodomain target specificity in cell culture
Cinzia Puppin, Dora Fabbro, Lucia Pellizzari, et al.
Oncology Reports
|
December 15, 2010
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells
Cinzia Puppin, Nadia Passon, Alessandra Franzoni, et al.
Oncology Reports
|
May 28, 2011
Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines
Cinzia Puppin, Fabio Puglisi, Maura Pandolfi, et al.
Molecular and Cellular Endocrinology
|
September 18, 2012
The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines
Elisa Lavarone, Cinzia Puppin, Nadia Passon, et al.
Virchows Archiv : an International Journal of Pathology
|
June 20, 2013
One-step nucleic acid amplification (OSNA) for intraoperative evaluation of sentinel lymph node status in breast cancer: a comparative study between CK19 protein expression and CK19 mRNA level in primary tumors and lymph node metastasis
Enrico Pegolo, Cinzia Puppin, Anna Gerometta, et al.
Molecular and Cellular Biochemistry
|
June 26, 2009
Conservation across species identifies several transcriptional enhancers in the HEX genomic region
Angela Valentina D'Elia, Elisa Bregant, Nadia Passon, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
February 4, 2011
In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription
Cinzia Puppin, Nadia Passon, Francesco Frasca, et al.
International Journal of Endocrinology
|
February 24, 2015
Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line
Federica Baldan, Catia Mio, Lorenzo Allegri, et al.
Expert Opinion on Therapeutic Targets
|
December 14, 2012
Targeting histone deacetylase in thyroid cancer
Diego Russo, Cosimo Durante, Stefania Bulotta, et al.
Oncology Reports
|
February 18, 2016
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells
Lorenzo Allegri, Federica Baldan, Catia Mio, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Molecular Biology Reports
|
March 4, 2011
Using the recognition code to swap homeodomain target specificity in cell culture
Cinzia Puppin, Dora Fabbro, Lucia Pellizzari, et al.
Oncology Reports
|
December 15, 2010
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells
Cinzia Puppin, Nadia Passon, Alessandra Franzoni, et al.
Oncology Reports
|
May 28, 2011
Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines
Cinzia Puppin, Fabio Puglisi, Maura Pandolfi, et al.
Molecular and Cellular Endocrinology
|
September 18, 2012
The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines
Elisa Lavarone, Cinzia Puppin, Nadia Passon, et al.
Virchows Archiv : an International Journal of Pathology
|
June 20, 2013
One-step nucleic acid amplification (OSNA) for intraoperative evaluation of sentinel lymph node status in breast cancer: a comparative study between CK19 protein expression and CK19 mRNA level in primary tumors and lymph node metastasis
Enrico Pegolo, Cinzia Puppin, Anna Gerometta, et al.
Molecular and Cellular Biochemistry
|
June 26, 2009
Conservation across species identifies several transcriptional enhancers in the HEX genomic region
Angela Valentina D'Elia, Elisa Bregant, Nadia Passon, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
February 4, 2011
In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription
Cinzia Puppin, Nadia Passon, Francesco Frasca, et al.
International Journal of Endocrinology
|
February 24, 2015
Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line
Federica Baldan, Catia Mio, Lorenzo Allegri, et al.
Expert Opinion on Therapeutic Targets
|
December 14, 2012
Targeting histone deacetylase in thyroid cancer
Diego Russo, Cosimo Durante, Stefania Bulotta, et al.
Oncology Reports
|
February 18, 2016
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells
Lorenzo Allegri, Federica Baldan, Catia Mio, et al.
Page
of 5